Work

Male MS Patients’ Safety, Tolerability and Efficacy Outcomes Do Not Differ from Female Patients Treated with Diroximel Fumarate: EVOLVE-MS-1 Ad-hoc Analysis (P8-3.017)

Year: 2023

Type: article

Source: Neurology

DOI: 10.1212/wnl.0000000000203524

Authors: Annette Wundes, John Lindsey, Hailu Chen, Matthew Scaramozza, Filipe Branco, Wanda Castro-Borrero, Sai Shankar, Robert Naismith

Institutions: University of Washington, The University of Texas Health Science Center at Houston, Biogen (United States), Washington University in St. Louis

Language: English

Topic: Multiple Sclerosis Research Studies

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4367304730

FWCI:

Cites:

Cited by:

Related to: 10